wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38273851-85C52756-F968-403B-8652-7464C9AFC1FC
Q38273851-85C52756-F968-403B-8652-7464C9AFC1FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38273851-85C52756-F968-403B-8652-7464C9AFC1FC
Postulated mechanisms of resistance of B-cell non-Hodgkin lymphoma to rituximab treatment regimens: strategies to overcome resistance.
P2860
Q38273851-85C52756-F968-403B-8652-7464C9AFC1FC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38273851-85C52756-F968-403B-8652-7464C9AFC1FC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2b33771fc77274a8763c6473ad6a5cf72048f2c5
P2860
Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma.